Hypromellose

Quick links to important sections

Hypromellose

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hypromellose

Quick Facts: Hypromellose Identity

Property Description
Active ingredient Hypromellose (Hydroxypropyl methylcellulose)
Form Ophthalmic solution or gel
Pharmacological class Ophthalmic Lubricant, Viscoelastic Agent
General use Relieving ocular dryness and irritation
Origin Semisynthetic cellulose derivative

What is Hypromellose (Hydroxypropyl Methylcellulose)?

Hypromellose, formally known as Hydroxypropyl methylcellulose (HPMC), is a large, biologically inert molecule classified as a semisynthetic polymer derived from cellulose. This active ingredient is engineered by chemically modifying natural cellulose, a process that yields a highly stable, water-soluble compound. As a pharmaceutical substance, Hypromellose is typically used as the single active compound in ophthalmic preparations designed for physical action on the eye's surface, formulated within an aqueous (water-based) vehicle. Its chemical structure, which includes both methyl and hydroxypropyl substitutions, contributes to its superior film-forming capacity, which contributes to enhanced surface contact time compared to simple saline solutions.


Classification and Form: An Ophthalmic Viscoelastic Agent

Hypromellose is primarily classified as an Ophthalmic Lubricant and a Viscoelastic Agent, belonging to the general category of Artificial Tears. Hypromellose is recognized as an official ingredient for these products. This classification denotes its role as a compound that alters the physical properties of a solution applied to the eye, rather than interacting chemically with biological receptors. It is most commonly prepared as a sterile ophthalmic solution (eye drops) or an ophthalmic gel designed for topical administration. The primary function of these products is to provide supplemental moisture to the eye's surface, which in turn reduces symptoms of dryness and ocular irritation.


General Purpose and Benefit to the Eye

The general purpose of Hypromellose is to provide lubrication and physical protection to the eye's surface, particularly the cornea and conjunctiva. The compound's viscosity-increasing property allows it to form a smooth, protective film that resists rapid drainage from the eye, providing superior corneal hydration. This ability to sustain a stable, moist layer makes Hypromellose beneficial for addressing the common discomfort associated with ocular dryness and the disruption of the natural precorneal tear film. A typical use scenario involves individuals who experience temporary eye strain and irritation due to prolonged screen exposure or environmental factors.

What side effects are possible with Hypromellose?

Possible Side Effects and Safety Information

The regulatory safety profile for Hypromellose ophthalmic solution is structured around effects documented locally in the eye, which is consistent with its classification as an inert lubricant with negligible systemic absorption. The officially listed undesirable effects primarily fall under the Eye Disorders System Organ Class.

Officially Documented Ocular Adverse Reactions

The majority of reported adverse reactions are typically transient (short-lived) and occur immediately following the instillation of the eye drops.

Frequency Classification Officially Listed Adverse Reactions
Not Known (Cannot be estimated from available data) Transient mild stinging on instillation, temporary blurred vision, eye pain, foreign body sensation in eyes, eye irritation, and ocular hyperaemia (eye redness).
Uncommon (Specific regulatory sources) Local burning, eye pain, and blurred vision.

Serious Adverse Reactions and Safety Constraints

A Very Rare occurrence of Corneal Calcification has been documented in association with the use of phosphate-containing formulations in patients with significantly damaged corneas.

Due to the physical properties of the solution, Hypromellose may prolong the contact time of other ophthalmic medicinal products that are applied concurrently.

Population-Specific Safety Considerations

Because of the compound's pharmacologically inert nature and negligible systemic exposure following topical application, official documentation indicates that no effects on the pregnant woman or the breastfed infant are anticipated. Likewise, the safety profile is not expected to differ substantially for use in pediatric or geriatric populations compared to younger adults.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Hypromellose (Hydroxypropyl methylcellulose) ophthalmic solutions is defined by the compound's chemical nature as a pharmacologically inert polymer with negligible systemic absorption. This leads to specific, limited mandates regarding overdose management in official labeling.

Documented Manifestations and Risk Profile

Entity Official Regulatory Statement
Expected Manifestations No toxic effects are expected from ocular over-application; regulatory documentation states there are no known reactions or adverse outcomes from this route.
Severe Outcomes None documented, consistent with the compound's inertness and lack of systemic activity.
Antidote No specific antidote is known or required.

Emergency Actions Mandated by Regulators

Governmental sources define two distinct scenarios for overdose response:

  1. Ocular Over-application: Should excessive solution be applied to the eye, the official guidance states that the overdose can be easily washed out of the eye with lukewarm tap water.
  2. Accidental Ingestion: The only scenario requiring urgent medical action is the accidental ingestion of the contents of the bottle. In this case, the label mandates the individual to seek medical help or contact a poison control center right away.

Connection to the Overall Overdose Profile

The official regulatory profile confirms that no systemic risks are anticipated from its intended topical use, thereby eliminating the need for complex monitoring in official documentation. Urgent medical attention is exclusively mandated by regulatory labeling for the accidental ingestion scenario, reflecting a general safety protocol for swallowed substances rather than an expected pharmacological toxicity.

Therapeutic Uses of Hypromellose

What Hypromellose Treats: Main Uses and Benefits

Hypromellose (Hydroxypropyl Methylcellulose) is commonly used as an ophthalmic lubricant, providing symptomatic relief for conditions where moisture and lubrication are needed on the eye's surface. It is generally applied to help with dryness and irritation of the eye.

Therapeutic Scope and Symptom Relief

This agent is considered relevant across domains where additional symptomatic support is needed, primarily focusing on conditions characterized by periods of heightened symptoms of insufficient tear film, such as Dry Eye Disease (DED) and Keratoconjunctivitis Sicca. It may be used to address symptom clusters that may become intense or disruptive, including persistent grittiness, burning, soreness, and the sensation of having a foreign body in the eye. It is relevant for managing symptoms associated with both chronic conditions and situational triggers, such as prolonged screen use or exposure to drying environments. It may help patients cope more steadily with symptom fluctuations and contributes to easing the overall symptom load.

Supportive Ocular Surface Protection

Hypromellose is applied when appropriate in contexts requiring enhanced surface lubrication, particularly for contact lens users (e.g., hard lenses) and as part of supportive care following certain eye procedures. This provides support that helps ease the overall symptom burden and may assist with maintaining stability when symptoms interfere with routine activities.


Quick Fact: Relief for Ocular Discomfort

Symptom Focus Application Context Primary Benefit
Symptoms related to physical discomfort Chronic DED, Environmental strain Provides supportive relief, Helps ease distress
Symptoms related to inflammatory or irritative states Contact lens use, Post-operative care Enhanced surface lubrication, Assists with maintaining functional stability

Regulatory References

  1. DailyMed (NIH/NLM) Drug Labeling Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Hypromellose?

The population eligibility for Hypromellose ophthalmic solutions is strictly defined by government regulatory agencies, focusing on hypersensitivity and specific age groups.


Contraindications and Restrictions

Classification Rule (Based on Official Labeling)
Absolute Contraindication Individuals with a known hypersensitivity (allergy) to Hypromellose or to any of the product's excipients must not use the medicine.
Conditional Use Products containing preservatives like benzalkonium chloride are restricted for soft contact lens wearers, who must remove lenses before use and wait a specified time before reinserting.

Age and Physiological Eligibility

Adults and the Elderly are generally considered eligible for standard use. For pediatric populations, eligibility differs by region: some authorities state that safety and efficacy have not been established for children under 18 years, while US labeling requires users to “ask a doctor” before use in children under 6 years of age.

Use during Pregnancy and Lactation is addressed regionally. Some regulatory bodies permit use, noting that negligible systemic exposure means no effects are anticipated. Conversely, other labels advise patients to “ask a health professional before use.” The medicine is not systemically absorbed, so no restrictions are documented for patients with hepatic or renal impairment.

What should I know about interactions with other medicines?

Hypromellose Interactions with other medicines and products

Regulatory documentation confirms that Hypromellose (Hydroxypropyl methylcellulose) ophthalmic solution is a pharmacologically inert substance with negligible systemic absorption when applied to the eye. Consequently, the medicine does not participate in systemic drug–drug interactions, including those mediated by liver enzymes, drug transporters, or other common metabolic pathways. Official labeling documents report no interactions with food, alcohol, supplements, or herbal products.


The interaction profile is officially defined by a local physicochemical effect related to its use as a viscoelastic agent. When Hypromellose is co-administered with other topical ophthalmic medicines (such as eye drops or solutions), its viscosity-enhancing property results in a prolongation of the contact time or local ocular surface exposure of the co-administered drug.

Due to this local effect, regulatory authorities mandate a timing-based administration rule when using multiple ophthalmic products. Hypromellose and any other eye drops must be separated by a specific time interval, which is typically documented as at least 5 minutes between applications. This timing rule is the primary interaction-related restriction found in regulatory prescribing information. Furthermore, if an eye ointment is part of a regimen with Hypromellose, the ointment should consistently be applied last to prevent interference with the other products' absorption.

Mechanism of Action

Hypromellose (Hydroxypropyl methylcellulose) is a pharmacologically inert polymer that achieves its physiological effects through physical, rheological, and surface-active mechanisms, entirely bypassing the chemical signaling required for classical drug activity (receptors, enzymes, etc.). Its action is strictly local and determined by the polymer's physical properties.

Rheological Modulation and Prolonged Surface Adhesion

Hypromellose acts as a viscoelastic agent, primarily targeting the ocular surface epithelium and the precorneal tear film structure. This mechanism increases the thickness (viscosity) of the solution while enabling shear-thinning behavior—a process where the fluid thins briefly during a blink, allowing for smooth distribution with reduced mechanical friction. This mucoadhesive action ensures the solution physically adheres to the eye's surface, which prolongs the residence time and contact between the solution and the tissue.

Tear Film Stabilization and Barrier Function

The result of the polymer's extended adhesion and film-forming capacity is the stabilization of the tear film dynamics. By creating a robust, cohesive, and continuous surface layer, Hypromellose mechanically reduces the rate of evaporative water loss and influences the rapid breakup of the aqueous layer. This barrier function provides a mechanical boundary for the underlying corneal epithelial cells, influencing stress associated with desiccation and friction.

Dosage and Administration Information

Hypromellose (Hydroxypropyl methylcellulose) administration follows specific protocols regarding its topical route, standard dosing, and procedural requirements for ocular use.


Official Administration Guidelines

Administration Scope Application Details
Route of Administration The method of use is topical instillation (direct application) to the eye only.
Standard Dosing Schedule The standard regimen involves applying one to two drops into the affected eye(s).
Frequency Pattern Application is typically performed three to four times daily or may be used on an as-needed basis.
Age-Group Rules Standard dosage applies to adults, children, and the elderly, as the medication acts locally and systemic absorption is negligible.

Procedural Instructions and Constraints

The correct use of Hypromellose requires adherence to specific application protocols to maintain efficacy and sterility:

  • Contact Lens Restriction: Soft contact lenses must be removed before applying the drops. Lenses should not be reinserted until at least 15 minutes after administration.
  • Multi-Drop Timing: If multiple topical ophthalmic products are being used, Hypromellose must be administered with a separation of at least five to fifteen minutes from other eye drops to prevent dilution or washout.
  • Sterility: To maintain cleanliness, the dropper tip should not touch the eye, eyelids, or any other surface during application.
  • Course Duration: This medication is used for both short-term relief and as a component of long-term care for chronic conditions. However, the container must be discarded 28 days after the first opening.

This framework ensures the medication is applied directly to the ocular surface under conditions that support its intended function.

Recent Clinical Evidence

Research evidence / Overview of studies for Hypromellose

Evidence for Symptom Relief for Dry Eyes

Research has involved Randomized Controlled Trials (RCTs) and systematic reviews that were conducted during periods of increased symptom activity. These studies research examined how symptoms change over time in patients with insufficient natural tears. The populations studied were typically adults experiencing persistent grittiness, soreness, and foreign body sensation—outcomes related to physical discomfort and ocular irritation.

Studies explored various measures of short-term change, including patient-reported outcomes describing perceived discomfort and objective checks of the eye’s surface. Findings describe patterns observed in the studies related to short-term changes in ocular surface metrics. Comparative trials and reviews research explored the relationship of the substance’s use to short-term or episodic symptom patterns.

Evidence for Ocular Surface Protection

Hypromellose was studied for purposes beyond general dryness relief, specifically in research contexts involving fluctuating or unstable symptoms tied to mechanical stress on the eye. Observational studies and practical compatibility assessments research examined the use of this substance for individuals wearing hard contact lenses and those requiring support following certain eye procedures. The outcomes monitored included the maintenance of the eye's physical surface integrity and outcomes reflecting daily functioning or activity level affected by surface irritation.

In these supportive scenarios, evidence is often derived from settings with varying symptom burdens. The evidence quality varies across studies, and the base is generally composed of smaller, targeted observational studies rather than large-scale, long-term RCTs.

What Remains Uncertain in the Research

While Hypromellose was studied for a clear purpose, several key limitations exist in the research landscape. Comparative evidence is lacking for a direct, systematic comparison of Hypromellose against all newer classes of prescription therapies that target the underlying disease processes of chronic dry eye, meaning the evidence base focuses on physical action rather than targeting disease processes.

The results apply only to the populations studied, and long-term effects are not fully established regarding consistent use over many months or years. The studies contribute to the broader evidence landscape, but findings describe group patterns, not personal outcomes.

Key Studies & References

  1. Ophthalmic Lubricants - NIH Review (StatPearls)
  2. Hypromellose Ophthalmic Solution Drug Labeling Information - DailyMed (NIH/NLM)

Frequently Asked Questions (FAQ)

Common questions about Hypromellose (FAQ)


Q: Is Hypromellose the same thing as artificial tears?

Hypromellose is the active ingredient used in many products known as artificial tears. According to regulatory documents, Hypromellose is officially classified as an Ophthalmic Demulcent, a type of substance that acts physically on the eye to provide lubrication and relief from dryness.


Q: Why does the packaging list Hypromellose as a lubricant?

Hypromellose is officially classified as an Ophthalmic Lubricant. This classification reflects its mechanism of action as an inert polymer that increases the solution’s thickness, or viscosity. This physical property helps the product coat and protect the surface of the eye for lubrication.


Q: Is Hypromellose considered a preservative-free eye product?

Hypromellose is available in both formulations that contain preservatives and those that are preservative-free. The decision to use either type depends on the specific product and manufacturer. If a product contains preservatives like benzalkonium chloride, regulatory warnings typically apply regarding contact lens use.


Q: Are there any known issues with using contact lenses while using Hypromellose?

Soft contact lenses should be removed before application. Regulatory warnings mention this is particularly relevant for products with preservatives, as the lenses may absorb the preservative. Lenses should not be reinserted until at least 15 minutes after the administration.


Q: Does Hypromellose cause blurry vision right after application?

Yes, regulatory safety profiles list temporary blurred vision as a commonly reported undesirable effect. This often occurs immediately following the instillation of the drops and is often associated with the product coating the eye's surface.


Q: How quickly should I expect to feel relief after using Hypromellose?

Official product information describes the action as providing rapid symptom relief from dry eye discomfort. This effect is due to the polymer’s physical mechanism of creating a lubricating film on the surface of the eye upon application.


Q: What is the difference between Hypromellose and carboxymethylcellulose?

Both Hypromellose and Carboxymethylcellulose are distinct types of cellulose derivative polymers. They are both classified by the FDA as Ophthalmic Demulcents, meaning they share the same regulatory classification for providing lubrication and physical relief to the surface of the eye.


Q: What is the difference between Hypromellose and polyethylene glycol (PEG)?

Hypromellose is a cellulose derivative, while Polyethylene Glycol (PEG) is a polyol; both are distinct active ingredients. Both substances are classified as Ophthalmic Demulcents by the FDA, used for the same general purpose of ocular lubrication.


Q: Is it safe to drive or operate machinery immediately after using Hypromellose?

Because temporary blurred vision is a reported side effect, regulatory warnings suggest avoiding driving or operating machinery until the temporary blurred vision has cleared. This is a common precaution for eye products that may briefly affect vision.


Q: What is the shelf life of Hypromellose drops once the bottle is opened?

The multi-dose container typically has a stability limit defined by regulatory requirements. Official instructions mandate that the container should be discarded 28 days (four weeks) after the date of first opening to maintain sterility and product integrity.


Q: Can you use Hypromellose more than four times a day?

The standard regulatory regimen is typically described as three to four times daily or on an as-needed (PRN) basis. While higher frequencies may be used, such as hourly use in severe cases, this is based on a healthcare professional's assessment.


Q: Is it normal to have a slight stinging sensation after using Hypromellose drops?

Yes, official safety information lists transient mild stinging as a common undesirable effect. This feeling can occur upon the initial instillation of the drops and is generally recognized as a short-lived occurrence.


Q: What does 'viscosity' mean in relation to Hypromellose eye drops?

Viscosity is a descriptive term for the solution's thickness or resistance to flow. Hypromellose is a viscoelastic agent, and its purpose is to increase the solution’s viscosity. This physical effect allows the product to prolong its contact time and provide effective lubrication on the eye's surface.


Q: Does the concentration of Hypromellose (e.g., 0.3% vs 0.5%) make a difference in how it feels?

Regulatory standards allow the ingredient to be used across a range of concentrations. Higher concentrations are generally associated with increased viscosity. This higher thickness may lead to a higher potential for temporary visual blur immediately after application.


Q: Can I use Hypromellose if I have glaucoma?

Official warnings advise that individuals with pre-existing medical problems, including a history of glaucoma, should consult a health professional before use. As the product is not systemically absorbed, a healthcare provider can determine its use in combination with existing eye medications.


Q: Does Hypromellose have a specific warning label for people with certain medical conditions?

General regulatory precautions advise that people with certain chronic conditions, such as diabetes or a history of glaucoma, should consult a health professional before using the product. This ensures an individualized assessment of its appropriateness.


Q: Can Hypromellose be used for conditions other than dry eyes?

Yes, in addition to relief for general dry eye symptoms, regulatory indications and research support its use for other purposes. These include managing conditions like kerato-conjunctivitis sicca, moisturizing hard contact lenses, and lubricating ocular prosthetics (artificial eyes).


Q: What are the signs that Hypromellose drops are not working for me?

Regulatory warnings state that medical consultation is necessary if specific symptoms occur. These signs include eye pain, changes in vision, continued redness or irritation, or if the underlying eye condition appears to worsen or persists.


Q: Is it possible for Hypromellose to worsen dry eye symptoms?

Official labeling states that a healthcare professional should be consulted if irritation persists or increases, or if the eye condition appears to worsen. This warning is in place because such outcomes are recognized as a possibility that warrants professional evaluation.


Q: Does Hypromellose help with redness in the eyes?

Hypromellose is primarily indicated as a lubricant to relieve dryness and irritation. It is not indicated as a primary treatment for eye redness itself. In fact, ocular hyperaemia (eye redness) is listed in regulatory profiles as a potential undesirable effect of the product.


Q: Is Hypromellose a type of cellulose?

Yes, Hypromellose is formally defined as a semisynthetic polymer that is derived from natural cellulose. It is classified chemically as a cellulose ether, meaning it is a compound that is chemically modified from cellulose for pharmaceutical use.


Q: Is Hypromellose used in other types of medicine, like pills?

Yes, Hypromellose is commonly used in other types of medicine, although not as the active ingredient. It functions as an inactive ingredient, or excipient, in oral tablets and capsules, often to act as a binder or to help control the release of the medicine over time.


Q: Is Hypromellose regulated by the FDA?

Yes, the use of Hypromellose in ophthalmic preparations is regulated by the FDA. It is officially listed as an approved active ingredient for use as an Ophthalmic Demulcent in the Over-the-Counter (OTC) Drug Monograph.

How should Hypromellose be stored and disposed of?

How to Store and Dispose of Hypromellose

Hypromellose ophthalmic solutions must be stored according to regulatory requirements to preserve product sterility and stability.

Storage and Stability Rules

Condition Requirement
Temperature Store at room temperature, typically below 25°C or 30°C.
Prohibited Environment Must be protected from freezing and should not be refrigerated.
Container Integrity The container must be kept tightly closed; the cap must be replaced after use.
Post-Opening Limit Discard the multidose bottle 28 days (four weeks) after first opening. Single-dose containers must be discarded immediately after use.

Disposal and Safety

The medicine must be stored out of the sight and reach of children.

Official disposal rules mandate that the product must not be thrown away via wastewater or household waste. Unused or expired medication should be returned to a pharmacist for disposal according to local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hypromellose found in:

A-Z Index: